Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-089 for smoking abstinence symptoms
NCT01756053Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pozanicline in nicotine dependence, sponsored by University of Pennsylvania. Started Mar 2013; status: terminated.
02
Drugs
pozanicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01756053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756053.